Goldina Erowele

Bio

Dr Erowele, clinical pharmacist and cofounder at CareNovateMag.com [http://www.carenovatemag.com], a free caregiving, social health and medication literacy web-resource. CareNovateMag.com provides timely, relevant and doable information to help family & professional caregivers, patients, families, healthcare extenders, consumers, seniors and most of all WOMEN with health, wellness and caregiving. CareNovateMag.com offers also offers instructive content through their twice weekly email communications and newsletter. Prior to pharmacy, Dr Erowele was a certified nursing assistant (CNA), passionate about helping the senior and elderly population. Attended Howard University College of Pharmacy and completed a year pharmacy practice residency program at the VAMC in Washington, D.C. Practiced at the Walter Reed Army Medical Center as a pharmacotherapy specialist in areas of geriatrics, formulary management, internal medicine, intensive care. While there, she had spearheaded, developed and implemented clinical pharmaceutical services.

As a clinical pharmacy specialist, she also manages & cordinates a multi-million hematology oncology pharmaceutical budget in a Houston, TX Hospital.  She serves as an adjunct professor at the College of Pharmacy & Health Sciences, where she lectures on various topics. She has authored and coauthored several pharmacy journals, book chapters and serves as a reviewer to multiple journals. She received the U.S. Army Commander’s Award for Civilian Service in 2005 and 2006 & the 2007 Mel Liter Clinical Pharmacy Award.  She is a member of the Kappa Epsilon Society (an honor society for pharmacy professions), a wife, sister, mom and a friend.

Specialties:

Affiliation:

  • CareNovateMag

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Pain Medicine:

    THURSDAY, July 24, 2014 (HealthDay News) -- A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

    Called Targiniq ER and made by Purdue Pharma, the pill is a co...Full Article

  • Sharecare News
    Sharecare News posted a story about Pharmacy:

    THURSDAY, July 24, 2014 (HealthDay News) -- Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other therapies are ineffective or unavailable.<

    ...Full Article
  • Sharecare News
    Sharecare News posted a story about Pain Medicine:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Even though its use is often advised by doctors, the painkiller acetaminophen -- best known as Tylenol -- does not help treat lower back pain, according to a new Australian study.

    The researchers found the drug was no more effective than a dum...Full Article

  • Sharecare News
    Sharecare News posted a story about Infectious Disease:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- For patients infected with both HIV and hepatitis C, HIV antiretroviral therapy may help control both viruses, a small study suggests.

    Researchers said doctors could use their findings to improve treatment strategies for people with the two di...Full Article

  • Sharecare News
    Sharecare News posted a story about Hematology:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) and small lymphocytic lymphoma (SLL), the

    ...Full Article
  • Sharecare News
    Sharecare News posted a story about Infectious Disease:

    THURSDAY, July 17, 2014 (HealthDay News) -- Antiviral drugs aren't prescribed often enough for patients at high risk for flu complications, while too many of them receive unneeded antibiotics, a new study says.

    The findings show that doctors require more trainin...Full Article

  • Sharecare News
    Sharecare News posted a story about Hospice & Palliative Care:

    WEDNESDAY, July 16, 2014 (HealthDay News) -- Antibiotics are given to many hospice patients, although there's little proof the medicines benefit them, a new study shows.

    About 21 percent of patients who go directly from hospitals to hospice care for the terminally ill leave the hospital w...Full Article

  • Sharecare News
    Sharecare News posted a story about Addiction Medicine:

    TUESDAY, July 8, 2014 (HealthDay News) -- Combining two anti-smoking approaches -- the medication Chantix and nicotine patches -- improves the odds you'll quit smoking over the short term, a new industry-funded study suggests.

    "The combination appears to be safe, although further studie...Full Article

  • Sharecare News
    Sharecare News posted a story about Hospice & Palliative Care:

    MONDAY, July 7, 2014 (HealthDay News) -- Hospice care is an option for people who have terminal illnesses, but choosing the right hospice isn't always easy, experts say.

    "Choosing a hospice to care for yourself or a loved one in the final months or even days of life is an important and ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, July 3, 2014 (HealthDay News) -- Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).

    Some 70,800 Americans will be diagnosed w...Full Article

  • Sharecare News
    Sharecare News posted a story about Allergy / Immunology:

    WEDNESDAY, July 2, 2014 (HealthDay News) -- A new inhaled medication has the potential to treat mild asthma and allergies by interrupting the production of an immune system protein that triggers allergic reactions, a new study reports.

    The drug, quilizumab, targets the blood cells that pr...Full Article

  • Sharecare News
    Sharecare News posted a story about Hepatology:

    TUESDAY, July 1, 2014 (HealthDay News) -- Although it looked promising in early studies, the drug everolimus didn't improve survival for people with advanced liver cancer in its latest trial, a new study found.

    The findings from the phase 3 clinical trial are disappointing because earlie...Full Article

  • Sharecare News
    Sharecare News posted a story about Pain Medicine:

    TUESDAY, July 1, 2014 (HealthDay News) -- Doctors in some states seem to wield a freer hand issuing prescriptions for powerful narcotic medications, leading to wide variations in narcotic drug use among states, U.S. health officials reported Tuesday.

    Physicians in Alabama -- the state wit...Full Article

  • Sharecare News
    Sharecare News posted a story about Mental Health:

    MONDAY, June 30, 2014 (HealthDay News) -- A medication commonly used to treat HIV appears to double the risk that patients will develop suicidal thoughts or take their lives, new research contends.

    The finding concerns the anti-HIV drug efavirenz, which is marketed as Sustiva.

    Pr...Full Article

  • Sharecare News
    Sharecare News posted a story about Geriatrics Nursing:

    MONDAY, June 30, 2014 (HealthDay News) -- With higher rates of illness but fewer adult children to care for them, many of America's baby boom generation may find themselves unable to pay for the nursing home care they need, a new study warns.

    Already, a growing number of older Americans a...Full Article